Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Porton Advanced and Ascle Therapeutics Collaborate on CAR-NK Cell Therapy

publication date: Nov 20, 2023

Suzhou Porton Advanced, a gene and cell therapy CDMO, formed a partnership with Chengdu’s Ascle Therapeutics to develop NK cells and gene and cell therapies for cancer prevention, beauty and anti-aging. Ascle’s lead candidate, ASC101, is a CAR-NK cell therapy that targets ROBO1, which it expects will have efficacy in 80% of solid tumors. In a preliminary IIT trial, ASC101 demonstrated a disease control rate of 76.5%. Ascle develops NK/CAR-NK anti-tumor immune cell therapy drugs. Porton Advanced will provide development, production and regulatory services for Ascle's NK cell project. Terms of the agreement were not disclosed. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here